Wednesday, 30 August 2017

PRO/EDR> Hepatitis B - Ireland: post-transfusion, seronegative blood

Hepatitis B -- Ireland
To minimize the risk of HBV infection through the route of transfusion:
1. Screening should be performed using a highly sensitive and specific HBsAg immunoassay (EIA/CLIA [enzyme immunoassay/chemiluminescent immunoassays]).
2. Screening using a highly sensitive and specific HBsAg rapid assay or particle agglutination assay may be performed in laboratories with small throughput, in remote areas or in emergency situations.
3. Screening for anti-HBc is not recommended as a routine. Countries

Read more about it at HealthMap Global Disease Alerts via http://bit.ly/2woLRSF

No comments:

Post a Comment